CVS Plans to Repurchase as Much as $6 Billion in Shares

CVS Caremark Corp., the largest provider of prescription drugs in the U.S., plans to buy back as much as $6 billion in shares.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.